The course will provide a broad overview of key topics in biostatistics that are frequently at the forefront of litigation involving drugs and medical devices. The course will include a review of basic concepts including relative risks, odds ratios, statistical significance and power, comparing proportions, survival analysis, Bayesian analysis, metanalysis, and common issues in trial clinical conduct. The course will also touch on how these concepts figure into judicial opinions. Participants will learn to identify common red flags and pit falls in statistical analysis, develop tools to more effectively conduct discovery and interface with experts, and develop a sense for how courts view and understand these issues.
Objections are among the most powerful — and most misunderstood — tools in a trial lawye...
Data privacy remains one of the most rapid areas of growth in the class action space. Plaintiffs con...
Class action litigation continues to expand in both number of filings and monetary exposure, with se...
Lawyers lose hundreds of billable and operational hours every year to poorly managed meetings. Unfoc...
The Aftermath of Scams and Cybercrime: A Practical Guide to Response and Recovery examines the immed...
New York City’s new Non-Primary Residence Property Surcharge—commonly known as the pied-...
Perfectionism is often rewarded in the legal profession. It drives attention to detail, thorough pre...
Class action waivers in arbitration agreements remain enforceable, but a decade of U.S. Supreme Cour...
AI tools are advancing faster than legal organizations can absorb them. This program examines why th...
Class action litigation presents significant legal and business challenges for employers and corpora...